South Korea clears AITRICS' AI software for predicting patient deterioration
AI startup AITRICS has obtained clearance from South Korea's Ministry of Food and Drug Safety for its AI monitoring solution.
The South Korean startup has developed VitalCare, an AI software for predicting a patient's risk of cardiac arrest, sepsis and death within 4-6 hours in the ICU. It tracks six vital parameters, 11...
Calif.-based Transcarent, a healthcare platform focused on self-insured employers, announced its partnership with Prescryptive Health, a healthcare technology company and owner of mobile pharmacy services platform MyRx.io.
Transcarent Pharmacy Care, the newly announced pharmacy benefit offering from the startup, selected Prescryptive Health's prescription intelligence platform to power its...
British multinational pharmaceutical and biotech company GSK announced a three-year agreement with a $70 million initial payment to expand its access to Tempus' AI-powered data library, including its de-identified patient data.
GSK says the collaboration will allow it to leverage the U.S.-based company's library to accelerate drug discovery in oncology, improve its clinical trial design,...
On Thursday GoodRx, best known for its drug-cost transparency tools, announced a platform for providers, allowing them to search for medication-cost information during appointments with patients.
Provider Mode, which is now launching out of beta, lets providers or other healthcare workers to search for medications at the point of care. They can input information on location, dosing and quantity,...
Roche, one of the largest pharma companies in Europe, has been expanding its ambitions in genomic and personalized medicine, emerging practices that use information about a patient's genetic profile or proteins to prevent, diagnose or treat disease.
Dr. Oliver Bleck, area head of Europe South at Roche, joined MobiHealthNews to discuss Roche's advancements in oncology, its current work in...
Capital Blue Cross and Mark Cuban Cost Plus Drug Company (MCCPDC) announced a collaboration to allow Capital members and community organizers to access lower-cost prescription drugs via MCCPDC.
MCCPDC is a public-benefit corporation and online pharmacy that provides patients access to medications at a lower cost by working directly with distributors and manufacturers, bypassing what Mark Cuban...
French multinational pharmaceutical and healthcare company Sanofi announced a partnership with New York-based TrialSpark, which offers a technology-based model for drug development.
TrialSpark's tools aim for more efficient trial design, faster trial completion and higher quality trial data. It acquires clinical-stage drugs from pharmaceutical and biotech companies and develops them using its...
This week Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies like AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund and Amazon Web Services, announced the formation of a new startup company dubbed OMEC.AI.
OMEC.AI aims to build a computational platform using AI that can help researchers assess the clinical trial readiness of a drug...
EHR data company nference on Wednesday launched its real-world evidence generation platform and expanded its existing partnership with the Mayo Clinic.
The platform, dubbed nSights, collects de-identified patient clinical data from academic medical centers, including clinical notes, radiology results, lab tests and electrocardiograms. The company said it will eventually add digital pathology and...
Lyfegen, which offers a platform for value-based contracting for high-cost drugs, announced it had raised $8 million in Series A funding.
The round was led by aMoon, with participation from APEX Ventures and other investors. The startup, which is headquartered in Switzerland and the U.S., offers software that aims to help pharma companies, payers, providers and medical technology companies adopt...
